Previous 10 | Next 10 |
RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that GPR Gesundhe...
Medical device company Asensus Surgical ( NYSE: ASXC ) has announced the sale of a Senhance Surgical System to the company's distribution partner in Germany. The digital laparoscopic platform will be placed at an end user oncology focused hospital. For further details see: ...
RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a Senhance ...
RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & ...
Asensus Surgical, Inc. (ASXC) Q3 2022 Results Conference Call November 10, 2022 04:30 PM ET Company Participants Mark Klausner - Investor Relations Anthony Fernando - President and Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conferen...
Asensus Surgical ( NYSE: ASXC ) missed on the top line in its Q3 2022 financial results as revenue of $2.56M was a 0.4% year-over-year decline. Consensus estimate was $2.92M. Net loss in the quarter widened ~18% to $18.9M compared to the prior-year period (-$0.08 per s...
Asensus Surgical press release ( NYSE: ASXC ): Q3 Non-GAAP EPS of -$0.07. Revenue of $2.56M (-0.4% Y/Y). For further details see: Asensus Surgical Non-GAAP EPS of -$0.07, revenue of $2.56M
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operati...
First Hospital to Initiate a Senhance System Dedicated to Pediatric Procedures 9th Hospital in Germany to Utilize Senhance RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digit...
The following slide deck was published by Asensus Surgical, Inc. in conjunction with this event. For further details see: Asensus Surgical (ASXC) Investor Presentation - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Asensus Surgical Inc Com Company Name:
ASXC Stock Symbol:
NYSE Market:
Asensus Surgical Inc Com Website:
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement ...
RESEARCH TRIANGLE PARK, N.C., June 24, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital...
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: ICC Holdings, Inc. (NASDAQ:ICCH)'s ...